➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Johnson and Johnson
McKesson
Dow
Express Scripts

Last Updated: October 23, 2021

DrugPatentWatch Database Preview

Haloperidol - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic drug sources for haloperidol and what is the scope of freedom to operate?

Haloperidol is the generic ingredient in six branded drugs marketed by Ortho Mcneil, Ortho Mcneil Pharm, Cycle Pharms Ltd, Duramed Pharms Barr, Innogenix, Lederle, Mylan, Par Pharm, Purepac Pharm, Quantum Pharmics, Royce Labs, Sandoz, SCS, Upsher Smith Labs, Vintage, Watson Labs, Zydus Pharms Usa, Janssen Pharms, Fresenius Kabi Usa, Gland Pharma Ltd, Hong Kong, Hospira, Mylan Labs Ltd, Sandoz Inc, Somerset Theraps Llc, Teva Pharms Usa, West-ward Pharms Int, Zydus Pharms, Alpharma, Lannett Co Inc, Morton Grove, Pharm Assoc, Teva, Teva Pharms, Hikma Pharms, Abraxis Pharm, Akorn, Baxter Hlthcare Corp, Fosun Pharma, Marsam Pharms Llc, Sagent Pharms, Smith And Nephew, Solopak, and Actavis Mid Atlantic, and is included in one hundred and eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for haloperidol. Nineteen suppliers are listed for this compound.

Drug Prices for haloperidol

See drug prices for haloperidol

Drug Sales Revenue Trends for haloperidol

See drug sales revenues for haloperidol

Recent Clinical Trials for haloperidol

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ottawa Hospital Research InstitutePhase 1/Phase 2
Foothills Medical CentrePhase 1/Phase 2
Providence HospitalPhase 1/Phase 2

See all haloperidol clinical trials

Pharmacology for haloperidol
Medical Subject Heading (MeSH) Categories for haloperidol
Anatomical Therapeutic Chemical (ATC) Classes for haloperidol

US Patents and Regulatory Information for haloperidol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan HALOPERIDOL haloperidol TABLET;ORAL 070278-002 Jul 16, 2009 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Innogenix HALOPERIDOL haloperidol TABLET;ORAL 071173-004 Jan 2, 1987 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Sagent Pharms HALOPERIDOL haloperidol lactate INJECTABLE;INJECTION 200742-001 Sep 2, 2011 AP RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Watson Labs HALOPERIDOL haloperidol TABLET;ORAL 072353-001 Aug 27, 1991 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Innogenix HALOPERIDOL haloperidol TABLET;ORAL 071173-006 Jan 7, 1988 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Ortho Mcneil Pharm HALDOL SOLUTAB haloperidol TABLET;ORAL 017079-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for haloperidol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-005 Approved Prior to Jan 1, 1982 ⤷  Try it Free ⤷  Try it Free
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-001 Approved Prior to Jan 1, 1982 ⤷  Try it Free ⤷  Try it Free
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-003 Approved Prior to Jan 1, 1982 ⤷  Try it Free ⤷  Try it Free
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-004 Approved Prior to Jan 1, 1982 ⤷  Try it Free ⤷  Try it Free
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-006 Feb 2, 1982 ⤷  Try it Free ⤷  Try it Free
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-002 Approved Prior to Jan 1, 1982 ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Johnson and Johnson
McKesson
Dow
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.